Is idiopathic pulmonary fibrosis a cancer-like disease?: Transcriptome analysis to fuel the debate

C Arnold Spek; JanWillem Duitman

doi:https://doi.org/10.1183/23120541.00157-2018

Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Despite promising examples of anticancer drugs as potential treatment modalities for IPF, these transcriptome data argue against the general nature of anticancer drugs as anti-IPF drugs http://ow.ly/HjsV30nbcji.

Original language	English
Article number	00157-2018
Journal	ERJ open research
Volume	5
Issue number	1
DOIs	https://doi.org/10.1183/23120541.00157-2018
Publication status	Published - Feb 2019

Access to Document

https://doi.org/10.1183/23120541.00157-2018

https://openres.ersjournals.com/content/erjor/5/1/00157-2018.full.pdf

Cite this

@article{b74b6ee493754d04a000795f2f725721,

title = "Is idiopathic pulmonary fibrosis a cancer-like disease?: Transcriptome analysis to fuel the debate",

abstract = "Despite promising examples of anticancer drugs as potential treatment modalities for IPF, these transcriptome data argue against the general nature of anticancer drugs as anti-IPF drugs http://ow.ly/HjsV30nbcji.",

author = "Spek, {C Arnold} and JanWillem Duitman",

year = "2019",

month = feb,

doi = "https://doi.org/10.1183/23120541.00157-2018",

language = "English",

volume = "5",

journal = "ERJ open research",

issn = "2312-0541",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - Is idiopathic pulmonary fibrosis a cancer-like disease?

T2 - Transcriptome analysis to fuel the debate

AU - Spek, C Arnold

AU - Duitman, JanWillem

PY - 2019/2

Y1 - 2019/2

N2 - Despite promising examples of anticancer drugs as potential treatment modalities for IPF, these transcriptome data argue against the general nature of anticancer drugs as anti-IPF drugs http://ow.ly/HjsV30nbcji.

AB - Despite promising examples of anticancer drugs as potential treatment modalities for IPF, these transcriptome data argue against the general nature of anticancer drugs as anti-IPF drugs http://ow.ly/HjsV30nbcji.

U2 - https://doi.org/10.1183/23120541.00157-2018

DO - https://doi.org/10.1183/23120541.00157-2018

M3 - Article

C2 - 30723726

SN - 2312-0541

VL - 5

JO - ERJ open research

JF - ERJ open research

IS - 1

M1 - 00157-2018

ER -